Cell Viability Assays Market is Projected to grow at a CAGR of 8.4% from 2018 to 2023

“The global cell viability assays market is projected to grow at a CAGR of 8.4%.”

The cell viability assays market is expected to reach USD 4.16 billion by 2023 from an estimated USD 2.78 billion in 2018, at a CAGR of 8.4%. The rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research and rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics are the key drivers for market growth. However, the high cost of instruments is expected to restrain the growth of this market to a certain extent during the forecast period.

 

Request a Free Sample copy of This Premium Research Report:  https://watchersofmarkets.com/products/cell-viability-assays-market-by-product-mtt-assay-xtt-assay-calcein-resazurin-flow-cytometry-spectrophotometer-cell-type-human-animal-microbial-application-basic-research-stem-cell-discovery-development-global-forecast-to-2023#tab-questions

 

“The human cells segment to witness the highest growth during the forecast period.” On the basis of cell type, the cell viability assays market is segmented into human cells, animal cells, and microbial cells. The human cells segment is expected to register the highest CAGR during the forecast period. Growth in this segment is mainly due to the growing investments by government bodies and private sector organizations in research activities that are focused on developing new treatments for various human diseases.

 

“The stem cell research applications segment to witness the highest growth during the forecast period.”

On the basis of application, the cell viability assays market is segmented into drug discovery & development, basic research, stem cell research, clinical & diagnostic applications, and other applications. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research.

 

“APAC is projected to witness the highest growth during the forecast period.”

North America is expected to account for the largest share of the global cell viability assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.

 

Read More about this report: https://watchersofmarkets.com/products/cell-viability-assays-market-by-product-mtt-assay-xtt-assay-calcein-resazurin-flow-cytometry-spectrophotometer-cell-type-human-animal-microbial-application-basic-research-stem-cell-discovery-development-global-forecast-to-2023

 

The breakdown of primary participants was as mentioned below:

  • By Company Type: Tier 1–45%, Tier 2–40%, and Tier 3–15%
  • By Designation: C-level–43%, Director Level–30%, and Others–27%
  • By Region: North America–32%, Europe–27%, Asia Pacific–19%, and RoW–22%

 

The prominent players in the global cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).

 

Related Report:

Stem Cell Assay Market by Type (Viability Differentiation Cell Identification) Kit (Mesenchymal IPSCS Hematopoietic) Product (Flow Cytometer Detection Kit) Application (Regenerative Medicines Drug Development) End User - Forecast to 2021

The global stem cell assay market is expected to reach USD 1,363.3 million by 2021 from USD 536.6 million in 2016, at a CAGR of 20.5% from 2016 to 2021. Factors such as high prevalence of chronic diseases, increasing investment in research related activities, and technological advancements are driving the growth in the global stem cell assay market. However, stringent regulatory policies and the high cost of stem cell based therapies are the major factors restraining the growth of this market.

The global stem cell assay market has been segmented on the basis of type of assay, kit, detection, instrument, application, end-user, and region. The viability/cytotoxicity segment is expected to account for the largest and fastest-growing segment of the global stem cell assay market in 2016. The increasing focus of the pharmaceutical industries on drug screening has resulted in the increase in demand for stem cell assays.

Read More: https://watchersofmarkets.com/products/stem-cell-assay-market-by-type-viability-differentiation-cell-identification-kit-mesenchymal-ipscs-hematopoietic-product-flow-cytometer-detection-kit-application-regenerative-medicines-drug-development-end-user-forecast-to-2021

 

 About Us:

We are a leading market research store (headquartered in The Hague, Netherlands) bringing to you market research insights, analysis and data from many market research publishers around the globe.

Our experienced market research consultants understand a client’s research requirements in precise manner and get as many proposals around the globe as possible on the table suiting your budget and mapping your research goals.

Our only motivation is to provide clients with precise insights into their respective niche markets and offering them the most comprehensive portfolio of business information products.

 

Contact:

Watchers of Markets

Henriëtte van der Meydreef 144,2492 JG, Den Haag, Netherlands.

Website: https://watchersofmarkets.com/

Phone number: +31- 85 888 111 6

Email Id : [email protected]

Posted by on Friday September 14 2018, 9:16 AM EST. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals, Technology Hardware & Equipment, Technology, Media, & Telecommunications. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in